|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 33/10 | |
| A61K 35/612 | |||
| A61P 19/10 | |||
| A61K 31/663 |
| (11) | Number of the document | 2790710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12857932.3 |
| Date of filing the European patent application | 2012-12-13 | |
| (97) | Date of publication of the European application | 2014-10-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2012/050521 |
| Date | 2012-12-13 |
| (87) | Number | WO 2013/088440 |
| Date | 2013-06-20 |
| (30) | Number | Date | Country code |
| 201161569805 P | 2011-12-13 | US | |
| 201261680721 P | 2012-08-08 | US |
| (72) |
SAGI, Amir, IL
SHECHTER, Assaf, IL
SHALTIEL-GOLD, Galit, IL
DANIELY, Michal, IL
MEIRON, Oren, IL
|
| (73) |
Amorphical Ltd.,
P.O. Box 15021, 84210 Beer-Sheva,
IL
|
| (54) | AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF CALCIUM MALABSORPTION AND METABOLIC BONE DISORDERS |
| AMORPHOUS CALCIUM CARBONATE FOR THE TREATMENT OF CALCIUM MALABSORPTION AND METABOLIC BONE DISORDERS |